Nevertheless, some questions that remain unanswered in the current study and that merit future investigation: 1) identification of the molecular mechanisms that control GTSE1 to exert its effect on human HCC progression, and 2) further validation of the current findings in an animal model of the disease. The gene discussed is GTSE1; the disease is hepatocellular carcinoma.